03:49 PM EST - ProMetic Life Sciences Inc. : announced today that it has finalized the $10-million strategic equity investment in ProMetic by Shenzhen Hepalink Pharmaceutical Co., Ltd pursuant to the terms and conditions disclosed on October 16, 2012. ProMetic Life Sciences Inc.
shares T.PLI are trading up $0.03 at $0.30.
